Moreover, because AIP is inversely correlated with insulin sensitivity [36], this data together suggests that the insulin-sensitizing role of Pio would provide an antiatherogenic effect by targeting atherogenic dyslipidemia. This evidence concerns the gene AIP and metabolic syndrome.